Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 5,965

Document Document Title
WO/2013/018735A1
The purpose of the present invention is to provide a novel compound which has an anti-fungal activity on pathogenic fungi including fungi belonging to the genus Candida, the genus Aspergillus and the genus Trichophyton and is useful as a...  
WO/2013/019731A2
A compound of formula: wherein R1, L A, R, and n are defined herein, is useful for treating various disorders, including diarrhea.  
WO/2013/019731A3
A compound of formula: wherein R1, L A, R, and n are defined herein, is useful for treating various disorders, including diarrhea.  
WO/2013/014204A2
The present invention relates to compounds of the formula I, wherein Ht, G, R10, R30, R40, R50 and R60 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cat...  
WO/2013/014204A3
The present invention relates to compounds of the formula I, wherein Ht, G, R10, R30, R40, R50 and R60 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cat...  
WO/2013/012665A3
Embodiment of the present disclosure can include a compound, a structure bonded to the compound, and the like. In an embodiment, the compound can be a linker between an agent and a structure, where the agent can be a dye or a pigment and...  
WO/2013/012665A2
Embodiment of the present disclosure can include a compound, a structure bonded to the compound, and the like. In an embodiment, the compound can be a linker between an agent and a structure, where the agent can be a dye or a pigment and...  
WO/2013/004642A1
The present invention relates to a compound of formula (IA) The present invention also relates to the use of the compound of formula IA for treating certain neurodegenerative disorders characterized by cytotoxic TAU misfolding and/or agg...  
WO/2013/005157A1
Provided herein is novel compound of the general formula (I), its tautomeric forms, its stereoisomers, its analogs, its prodrugs, its isotopes, its N- oxides, its metabolites, its pharmaceutically acceptable salts, its polymorphs, its so...  
WO/2012/176856A2
To provide a novel pesticide. The present invention provides a compound represented by the formula (I) or its salt, and a pesticide containing it as an active ingredient: (I) wherein each of R1 and R2 is a hydrogen atom, a halogen atom, ...  
WO/2012/175654A1
Tetraline sulfonamides derivatives highly specific towards CA IX and/or CA XII human carbonic anhydrase for targeting solid tumors.  
WO/2012/176856A3
The present invention provides a compound represented by the formula (I) or its salt, and a pesticide containing it as an active ingredient: (I) wherein each of R1 and R2 is a hydrogen atom, a halogen atom, alkyl, haloalkyl, alkoxy, halo...  
WO/2012/170536A1
The present invention describes [1,2,4]thiadiazine 1,1-dioxide compounds and pharmaceutically acceptable salts thereof, which are useful in lowering serum uric acid in a patient in need thereof comprising administering to the patient a t...  
WO/2012/162323A1
A method for treating hypertension in a subject in need thereof (e.g., wherein said treatment does not result in an increase in serum uric acid levels, abnormally elevated serum uric acid levels, hyperuricemia, serum uric acid levels of ...  
WO/2012/149335A3
The invention relates to compositions having RGS (regulator of G-protein Signaling) inhibiting activity, and methods of use thereof. In some embodiments, RGS-inhibiting compositions find use in research on or treatment of disease states ...  
WO/2012/147516A1
[Problem] To provide a GPR40 activating agent having as an active ingredient a novel compound having a GPR40 agonist action, or a salt thereof, a solvate of the compound or salt, or the like; in particular, an insulin secretagogue or an ...  
WO/2012/149335A2
The invention relates to compositions having RGS (regulator of G-protein Signaling) inhibiting activity, and methods of use thereof. In some embodiments, RGS-inhibiting compositions find use in research on or treatment of disease states ...  
WO/2012/147764A1
Provided is a novel compound having NPY Y5 receptor antagonistic activity. It was discovered that a compound represented by (1) (where R1 is an optionally substituted alkyl and the like; p, q, and r are each independently 0 or 1; ring A ...  
WO/2012/149189A3
This disclosure relates to a photovoltaic cell that includes a first electrode, a second electrode, and a photoactive layer disposed between the first and second electrodes. The photoactive layer includes a photoactive polymer containing...  
WO/2012/149189A2
This disclosure relates to a photovoltaic cell that includes a first electrode, a second electrode, and a photoactive layer disposed between the first and second electrodes. The photoactive layer includes a photoactive polymer containing...  
WO/2012/142671A1
The present invention provides compounds of Formula (I): and salts, racemates, isomers, diastereoisomers, enantiomers, hydrates, solvates, N-oxides, pharmaceutically acceptable derivatives or prodrugs thereof. Also provided the use of th...  
WO/2012/140251A1
The invention relates to a rubber composition for the production of tyres, containing one or more diene elastomers, one or more reinforcing fillers and a vulcanisation system. The composition is characterised in that the vulcanisation sy...  
WO/2012/138734A1
In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula : (I) and tautomers and stereoisomers thereof, and pharmaceutically acceptable salts of said compounds, said ...  
WO/2012/126570A1
The invention relates to combinations having at least one bicyclic or tricyclic ring system, which is connected by acetylene ethylene or difluoroethylene bridges, to the application thereof in high frequency components, to liquid crystal...  
WO/2012/121168A1
The purpose of the present invention is to provide: a novel compound having an excellent CK2-inhibiting activity and high safety; and use applications of the compound. Provided are: a CK2 inhibitor comprising, as an active ingredient, a ...  
WO/2012/082893A2
High performance organic photovoltaic cells based on donor acceptor polymers in the active layer. A composition comprising: at least one copolymer comprising at least one first donor moiety and at least one first acceptor moiety in the c...  
WO/2012/082893A3
High performance organic photovoltaic cells based on donor acceptor polymers in the active layer. A composition comprising: at least one copolymer comprising at least one first donor moiety and at least one first acceptor moiety in the c...  
WO/2012/079164A1
The present invention is directed to activators of cylindrical proteases ("ACPs"), particularly ClpP, and the role thereof in the diagnosis and treatment of bacterial infections. A number of ACPs were identified that activate caseinolyti...  
WO/2012/077478A1
Aspects of the present invention can provide a novel phenanthrothiadiazole compound with the lowest excited triplet level T1 that is high, the phenanthrothiadiazole compound being capable of forming a stable amorphous film. Furthermore, ...  
WO/2012/070066A1
The present invention relates to a process for the preparation of substantially pure Taurolidine.  
WO/2012/062210A1
The compound of formula (I), pharmaceutically acceptable salts thereof, solvates thereof, chelates thereof, non-covalent complex thereof or produgs of compounds mentioned above or the mixture of any form above mentioned are provided. The...  
WO/2012/050484A3
The invention relates to organic chemistry, more specifically to novel biologically active compounds in the form of 5-amino-1,2,4-thiadiazole derivatives of general formula (I), where X may be ONO2 or NHR3; R1, R2, R3 may be the same or ...  
WO/2012/050484A2
The invention relates to organic chemistry, more specifically to novel biologically active compounds in the form of 5-amino-1,2,4-thiadiazole derivatives of general formula (I), where X may be ONO2 or NHR3; R1, R2, R3 may be the same or ...  
WO/2012/046869A1
[Problem] To provide a GPR40 activator, particularly an insulin secretion stimulator or a prophylactic and/or therapeutic agent for diabetes, obesity or the like, which contains a novel compound having a GPR40 agonistic activity, a salt ...  
WO/2012/029032A3
The present invention relates to heterocyclic compounds of Formula (1), in all their stereoisomeric and tautomeric forms; and their pharmaceutically acceptable salts, solvates, polymorphs, prodrugs, carboxylic acid isosteres and N-oxides...  
WO/2012/025638A1
The invention relates to selective, non-steroidal 17beta-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitors their production and use, especially for the treatment and/or prophylaxis of hormone-related diseases.  
WO/2012/019998A1
The invention relates to different methods for producing N'-(4-{[3-(4-chlorobenzyl)-1,2,4-thiadiazol-5-yl] oxy} -2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide.  
WO/2012/013728A1
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a...  
WO/2012/012307A1
Compounds of formula (I) and formula (II) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which ...  
WO/2012/012307A9
Compounds of formula (I) and formula (II) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which ...  
WO/2012/004714A3
The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to new s...  
WO/2012/006104A3
The present invention provides compounds which are potent inhibitors against Lpd activity, PDH activity, and/or the growth of tubercle bacillus, and thus are useful in the treatment of tuberculosis infection and associated conditions. Th...  
WO/2012/004714A2
The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to new s...  
WO/2012/006104A2
The present invention provides compounds which are potent inhibitors against Lpd activity, PDH activity, and/or the growth of tubercle bacillus, and thus are useful in the treatment of tuberculosis infection and associated conditions. Th...  
WO/2011/162514A3
The present invention provides a novel method for preparing [1,2,3]-oxathiazolidine-2,2-dioxide or [1,2,5]-thiadiazolidine-1,1-dioxide derivatives. According to the manufacturing method of the present invention, it is possible to conveni...  
WO/2011/162514A2
The present invention provides a novel method for preparing [1,2,3]-oxathiazolidine-2,2-dioxide or [1,2,5]-thiadiazolidine-1,1-dioxide derivatives. According to the manufacturing method of the present invention, it is possible to conveni...  
WO/2011/156655A2
Compounds that bind the glucagon-like peptide 1 receptor (GLP-1) receptor are provided including compounds which are modulators of the GLP-1 receptors and compounds which are capable of inducing a stabilizing effect on the receptor for u...  
WO/2011/152471A3
Provided is a rechargeable battery with a higher degree of safety. Specifically provided is a rechargeable battery constituted so as to prevent overcharging. The rechargeable battery is a battery which uses a positive electrode material ...  
WO/2011/152471A2
Provided is a rechargeable battery with a higher degree of safety. Specifically provided is a rechargeable battery constituted so as to prevent overcharging. The rechargeable battery is a battery which uses a positive electrode material ...  
WO/2011/132712A1
Provided is a novel compound that is useful as a medical drug in that said compound displays strong antimicrobial activity against gram-negative bacteria such as Pseudomonas aeruginosa and drug-resistant strains thereof, on the basis of ...  

Matches 201 - 250 out of 5,965